Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2175042Generated: November 2, 2026

cis-3-Boc-3,8-diazabicyclo[4.2.0]octane → (1S,6R)-3-(4,6-Dimethylpyrimidin-2-yl)-8-{[2-fluoro-6-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octane

https://huagongshe.com/reaction/2175042

Reaction equation

Participants

RoleNameHCIDCharge
Reactantcis-3-Boc-3,8-diazabicyclo[4.2.0]octaneHCID 16099092—
Reactant2-(3-Methyl-1,2,4-oxadiazol-5-yl)benzoic acidHCID 23146305—
Reactant(1S,6R)-3,8-Diazabicyclo[4.2.0]octan-8-yl(2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl)methanoneHCID 67086669—
Reactant2-Fluoro-6-(3-methyl-1,2,4-oxadiazol-5-yl)benzoic acidHCID 67086832—
Product(1S,6R)-3-(4,6-Dimethylpyrimidin-2-yl)-8-{[2-fluoro-6-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]carbonyl}-3,8-diazabicyclo[4.2.0]octaneHCID 67086602—

Reaction Steps

The title compound was prepared in a manner analogous to Intermediate 12, Step B substituting Intermediate 34 for (1R,6S) 3,8-diaza-bicyclo[4.2.0]octane-3-carboxylic acid tert-butyl ester and Intermediate 16 for 2-(3-methyl-1,2,4-oxadiazol-5-yl)benzoic acid. MS (ESI) mass calculated for C22H23FN6O2, 422.19; m/z found, 423.2.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09062044B2
Source datasetuspto-grants-2015_06
ORD IDord-279fa587ab00452c97ba056867be34ab
Source noteuspto-grants-2015_06